Retatrutide
SKU: 500 - 1000 Unit | check_circle In Stock
Retatrutide is an investigational peptide compound studied for its potential role in metabolic and weight-management research. It is designed to act as a triple receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By engaging multiple metabolic pathways, Retatrutide is being researched for its ability to influence appetite regulation, energy expenditure, and glucose metabolism. Early studies suggest it may support improved metabolic efficiency compared to single-pathway compounds, making it a subject of growing interest in scientific and pharmaceutical research. Retatrutide is intended strictly for laboratory and research use and is not approved for human consumption. Ongoing studies continue to evaluate its safety, efficacy, and long-term metabolic effects.
Product Overview
Retatrutide is an investigational peptide currently being studied for its potential effects on metabolic health and weight management. It is uniquely designed as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon receptors—three key pathways involved in appetite control, glucose regulation, and energy balance.
By activating these receptors simultaneously, Retatrutide is being researched for its ability to reduce appetite, enhance energy expenditure, and support metabolic efficiency. This multi-pathway approach differentiates it from single- or dual-agonist peptides and has made it a notable focus in advanced metabolic research.
Retatrutide remains under clinical investigation and is not approved for human use. It is supplied exclusively for laboratory and scientific research purposes, with ongoing studies assessing its long-term safety and efficacy.
biotech Clinical Research Summary
Quick Specs
Related Products
Selank (10mg)
Selank is a synthetic regulatory peptide originally developed through neuropeptide research. It is best known for its study in anxiety regulation, stress response, and cognitive function. Selank is a heptapeptide (seven amino acids) and is a modified analogue of tuftsin, a naturally occurring peptide involved in immune and nervous system
CJC-With DAC (2mg)
CJC-1295 with DAC is a long-acting synthetic peptide developed to stimulate the body’s natural release of growth hormone by mimicking Growth Hormone–Releasing Hormone (GHRH). The inclusion of DAC (Drug Affinity Complex) allows the peptide to bind to serum albumin, significantly extending its activity in the bloodstream. This results in sustained elevation of growth hormone and IGF-1 levels over time. CJC-1295 with DAC is widely studied in research settings for its potential role in muscle development, recovery processes, fat metabolism, tissue repair, and healthy aging mechanisms. It is intended strictly for research purposes only and is not approved for human or veterinary use.
Melanotan 1 (10mg)
Melanotan I (MT-1) is a synthetic peptide designed to mimic the effects of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring hormone involved in skin pigmentation. It works by stimulating melanocortin-1 (MC1) receptors in melanocytes, which increases the production of melanin, the pigment responsible for skin color. In research and clinical contexts, Melanotan I has been studied for its ability to promote skin tanning without UV exposure and for its potential photoprotective effects, as increased melanin may help protect the skin from UV radiation. It has also been investigated in studies related to photosensitivity disorders. ⚠️ Important clarification: Melanotan I is not related to melanoma (skin cancer). Despite similar wording, Melanotan I is a pigmentation peptide, not a cancer-related compound.
Samaglutide (10mg)
Semaglutide is a synthetic peptide that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of the natural GLP-1 hormone, helping regulate blood sugar levels and appetite. Semaglutide works by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting a feeling of fullness. Because of these effects, semaglutide is used in the management of type 2 diabetes and is widely studied for weight management and metabolic health. Its chemical structure allows for prolonged activity in the body, supporting sustained therapeutic effects.
